GlassScriptPhysician profile
Sean M Murphy
NPI 1922081223
$6,467.26
in general payments reported to CMS, 2019-2025
42 companies · $1,273 in 2025
The $1,273 reported for 2025 was more than what 81% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $509 · 2021: $604 · 2022: $748 · 2023: $1,094 · 2024: $1,558 · 2025: $1,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,840 · Education: $84.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,840.39 |
| Education | $84.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,077.94 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $862.35 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $600.16 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| United Therapeutics Corporation | $493.32 | 2022-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $323.96 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $317.71 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Takeda Pharmaceuticals U.S.A., INC. | $247.61 | 2022-2025 | Glassia, Hyqvia |
| Gilead Sciences, INC. | $242.74 | 2019-2024 | Veklury |
| Genzyme Corporation | $235.23 | 2021-2025 | |
| Mylan Specialty L.P. | $194.03 | 2019-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $183.26 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Baxter Healthcare | $175.53 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mallinckrodt Hospital Products INC. | $169.65 | 2020-2024 | Acthar |
| Actelion Pharmaceuticals US, INC. | $150.70 | 2021-2024 | Uptravi, Opsumit |
| Philips North America LLC | $118.58 | 2019-2024 | (Ak6) Vest Therapy |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.